Geoffrey Chin, Switzerland

Market Access Director, Novartis AG

Geoffrey Chin is currently the Global Market Access Lead for Heart Failure with Novartis AG based in Switzerland. Prior to commencing the position in January 2018, Geoffrey was working on several systems initiatives in Australia by partnering with primary care providers, hospital administrators and policy makers to improve patient outcomes. 

In addition, he has over 15 years' experience working in health technology assessment, reimbursement and pricing of medicines both in the commercial industry and academia. Geoffrey has a background in pharmacy with post graduate qualifications in public health.

View all speakers